Principal Financial Group Inc Immunity Bio, Inc. Transaction History
Principal Financial Group Inc
- $172 Billion
- Q4 2024
A detailed history of Principal Financial Group Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 11,593 shares of IBRX stock, worth $39,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,593Holding current value
$39,995% of portfolio
0.0%Shares
16 transactions
Others Institutions Holding IBRX
# of Institutions
207Shares Held
70MCall Options Held
1.64MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$58.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$39.4 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$29.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$13.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$7.75 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.38B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...